Cell therapy that repairs cornea damage with patient's own stem cells achieves positive phase I trial results - Medical Xpress
medicalxpress.comSubmitted by medicalxpress5525 in health
A team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation (CALEC), which was found to be…